Selected research
Market Structure
Global Medical Bioactive Glass Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Medical Bioactive Glass market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Medical Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Medical Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Medical Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Medical Bioactive Glass is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Medical Bioactive Glass include Zimmer Biomet Holdings, Inc., Stryker, SCHOTT, BonAlive Biomaterials, NovaBone, Beijing Xinfuyisheng High Technology, Prosidyan, Ferro and Mo-Sci Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Medical Bioactive Glass market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Medical Bioactive Glass and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Medical Bioactive Glass sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Bioactive Glass market size, projected growth trends, production technologies, key applications, and end-use industries.
Medical Bioactive Glass Segment by Company
Zimmer Biomet Holdings, Inc.
Stryker
SCHOTT
BonAlive Biomaterials
NovaBone
Beijing Xinfuyisheng High Technology
Prosidyan
Ferro
Mo-Sci Corporation
Synergy Biomedical
3M
Matexcel
Noraker
Ugulin
Kunshan Overseas Chinese Technology New Materials
Zhangjiagang Lanzhi Biotechnology
Guangzhou Kejin Material Technology
Medical Bioactive Glass Segment by Type
45S5
S53P4
Others
Medical Bioactive Glass Segment by Application
Bone Materials
Dental Materials
Cosmetics
Medical Bioactive Glass Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Bioactive Glass market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Bioactive Glass and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Bioactive Glass.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Medical Bioactive Glass market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Bioactive Glass manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Bioactive Glass in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Medical Bioactive Glass in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 45S5
- S53P4
- Others
Applications
- Bone Materials
- Dental Materials
- Cosmetics
Companies covered
- Zimmer Biomet Holdings, Inc.
- Stryker
- SCHOTT
- BonAlive Biomaterials
- NovaBone
- Beijing Xinfuyisheng High Technology
- Prosidyan
- Ferro
- Mo-Sci Corporation
- Synergy Biomedical
- 3M
- Matexcel
- Noraker
- Ugulin
- Kunshan Overseas Chinese Technology New Materials
- Zhangjiagang Lanzhi Biotechnology
- Guangzhou Kejin Material Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Medical Bioactive Glass Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Medical Bioactive Glass Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Medical Bioactive Glass Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Medical Bioactive Glass Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Medical Bioactive Glass Market Dynamics
- 2.1 Medical Bioactive Glass Industry Trends
- 2.2 Medical Bioactive Glass Industry Drivers
- 2.3 Medical Bioactive Glass Industry Opportunities and Challenges
- 2.4 Medical Bioactive Glass Industry Restraints
3 Medical Bioactive Glass Market by Manufacturers
- 3.1 Global Medical Bioactive Glass Revenue by Manufacturers (2021-2026)
- 3.2 Global Medical Bioactive Glass Sales by Manufacturers (2021-2026)
- 3.3 Global Medical Bioactive Glass Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Medical Bioactive Glass Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Bioactive Glass Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Medical Bioactive Glass Manufacturers, Product Type & Application
- 3.7 Global Medical Bioactive Glass Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Bioactive Glass Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Bioactive Glass Players Market Share by Revenue in 2025
- 3.8.3 2025 Medical Bioactive Glass Tier 1, Tier 2, and Tier 3
4 Medical Bioactive Glass Market by Type
- 4.1 Medical Bioactive Glass Type Introduction
- 4.1.1 45S5
- 4.1.2 S53P4
- 4.1.3 Others
- 4.2 Global Medical Bioactive Glass Sales by Type
- 4.2.1 Global Medical Bioactive Glass Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Medical Bioactive Glass Sales by Type (2021-2032)
- 4.2.3 Global Medical Bioactive Glass Sales Market Share by Type (2021-2032)
- 4.3 Global Medical Bioactive Glass Revenue by Type
- 4.3.1 Global Medical Bioactive Glass Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Medical Bioactive Glass Revenue by Type (2021-2032)
- 4.3.3 Global Medical Bioactive Glass Revenue Market Share by Type (2021-2032)
5 Medical Bioactive Glass Market by Application
- 5.1 Medical Bioactive Glass Application Introduction
- 5.1.1 Bone Materials
- 5.1.2 Dental Materials
- 5.1.3 Cosmetics
- 5.2 Global Medical Bioactive Glass Sales by Application
- 5.2.1 Global Medical Bioactive Glass Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Medical Bioactive Glass Sales by Application (2021-2032)
- 5.2.3 Global Medical Bioactive Glass Sales Market Share by Application (2021-2032)
- 5.3 Global Medical Bioactive Glass Revenue by Application
- 5.3.1 Global Medical Bioactive Glass Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Medical Bioactive Glass Revenue by Application (2021-2032)
- 5.3.3 Global Medical Bioactive Glass Revenue Market Share by Application (2021-2032)
6 Global Medical Bioactive Glass Sales by Region
- 6.1 Global Medical Bioactive Glass Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Bioactive Glass Sales by Region (2021-2032)
- 6.2.1 Global Medical Bioactive Glass Sales by Region (2021-2026)
- 6.2.2 Global Medical Bioactive Glass Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Bioactive Glass Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Medical Bioactive Glass Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Medical Bioactive Glass Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Medical Bioactive Glass Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Medical Bioactive Glass Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Medical Bioactive Glass Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Medical Bioactive Glass Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Medical Bioactive Glass Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Medical Bioactive Glass Revenue by Region
- 7.1 Global Medical Bioactive Glass Revenue by Region
- 7.1.1 Global Medical Bioactive Glass Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Medical Bioactive Glass Revenue by Region (2021-2026)
- 7.1.3 Global Medical Bioactive Glass Revenue by Region (2027-2032)
- 7.1.4 Global Medical Bioactive Glass Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Medical Bioactive Glass Revenue (2021-2032)
- 7.2.2 North America Medical Bioactive Glass Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Medical Bioactive Glass Revenue (2021-2032)
- 7.3.2 Europe Medical Bioactive Glass Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Medical Bioactive Glass Revenue (2021-2032)
- 7.4.2 Asia-Pacific Medical Bioactive Glass Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Medical Bioactive Glass Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Medical Bioactive Glass Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zimmer Biomet Holdings, Inc.
- 8.1.1 Zimmer Biomet Holdings, Inc. Company Information
- 8.1.2 Zimmer Biomet Holdings, Inc. Business Overview
- 8.1.3 Zimmer Biomet Holdings, Inc. Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zimmer Biomet Holdings, Inc. Medical Bioactive Glass Product Portfolio
- 8.1.5 Zimmer Biomet Holdings, Inc. Recent Developments
- 8.2 Stryker
- 8.2.1 Stryker Company Information
- 8.2.2 Stryker Business Overview
- 8.2.3 Stryker Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Stryker Medical Bioactive Glass Product Portfolio
- 8.2.5 Stryker Recent Developments
- 8.3 SCHOTT
- 8.3.1 SCHOTT Company Information
- 8.3.2 SCHOTT Business Overview
- 8.3.3 SCHOTT Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 SCHOTT Medical Bioactive Glass Product Portfolio
- 8.3.5 SCHOTT Recent Developments
- 8.4 BonAlive Biomaterials
- 8.4.1 BonAlive Biomaterials Company Information
- 8.4.2 BonAlive Biomaterials Business Overview
- 8.4.3 BonAlive Biomaterials Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 BonAlive Biomaterials Medical Bioactive Glass Product Portfolio
- 8.4.5 BonAlive Biomaterials Recent Developments
- 8.5 NovaBone
- 8.5.1 NovaBone Company Information
- 8.5.2 NovaBone Business Overview
- 8.5.3 NovaBone Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 NovaBone Medical Bioactive Glass Product Portfolio
- 8.5.5 NovaBone Recent Developments
- 8.6 Beijing Xinfuyisheng High Technology
- 8.6.1 Beijing Xinfuyisheng High Technology Company Information
- 8.6.2 Beijing Xinfuyisheng High Technology Business Overview
- 8.6.3 Beijing Xinfuyisheng High Technology Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Beijing Xinfuyisheng High Technology Medical Bioactive Glass Product Portfolio
- 8.6.5 Beijing Xinfuyisheng High Technology Recent Developments
- 8.7 Prosidyan
- 8.7.1 Prosidyan Company Information
- 8.7.2 Prosidyan Business Overview
- 8.7.3 Prosidyan Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Prosidyan Medical Bioactive Glass Product Portfolio
- 8.7.5 Prosidyan Recent Developments
- 8.8 Ferro
- 8.8.1 Ferro Company Information
- 8.8.2 Ferro Business Overview
- 8.8.3 Ferro Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Ferro Medical Bioactive Glass Product Portfolio
- 8.8.5 Ferro Recent Developments
- 8.9 Mo-Sci Corporation
- 8.9.1 Mo-Sci Corporation Company Information
- 8.9.2 Mo-Sci Corporation Business Overview
- 8.9.3 Mo-Sci Corporation Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Mo-Sci Corporation Medical Bioactive Glass Product Portfolio
- 8.9.5 Mo-Sci Corporation Recent Developments
- 8.10 Synergy Biomedical
- 8.10.1 Synergy Biomedical Company Information
- 8.10.2 Synergy Biomedical Business Overview
- 8.10.3 Synergy Biomedical Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Synergy Biomedical Medical Bioactive Glass Product Portfolio
- 8.10.5 Synergy Biomedical Recent Developments
- 8.11 3M
- 8.11.1 3M Company Information
- 8.11.2 3M Business Overview
- 8.11.3 3M Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 3M Medical Bioactive Glass Product Portfolio
- 8.11.5 3M Recent Developments
- 8.12 Matexcel
- 8.12.1 Matexcel Company Information
- 8.12.2 Matexcel Business Overview
- 8.12.3 Matexcel Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Matexcel Medical Bioactive Glass Product Portfolio
- 8.12.5 Matexcel Recent Developments
- 8.13 Noraker
- 8.13.1 Noraker Company Information
- 8.13.2 Noraker Business Overview
- 8.13.3 Noraker Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Noraker Medical Bioactive Glass Product Portfolio
- 8.13.5 Noraker Recent Developments
- 8.14 Ugulin
- 8.14.1 Ugulin Company Information
- 8.14.2 Ugulin Business Overview
- 8.14.3 Ugulin Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Ugulin Medical Bioactive Glass Product Portfolio
- 8.14.5 Ugulin Recent Developments
- 8.15 Kunshan Overseas Chinese Technology New Materials
- 8.15.1 Kunshan Overseas Chinese Technology New Materials Company Information
- 8.15.2 Kunshan Overseas Chinese Technology New Materials Business Overview
- 8.15.3 Kunshan Overseas Chinese Technology New Materials Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Kunshan Overseas Chinese Technology New Materials Medical Bioactive Glass Product Portfolio
- 8.15.5 Kunshan Overseas Chinese Technology New Materials Recent Developments
- 8.16 Zhangjiagang Lanzhi Biotechnology
- 8.16.1 Zhangjiagang Lanzhi Biotechnology Company Information
- 8.16.2 Zhangjiagang Lanzhi Biotechnology Business Overview
- 8.16.3 Zhangjiagang Lanzhi Biotechnology Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Zhangjiagang Lanzhi Biotechnology Medical Bioactive Glass Product Portfolio
- 8.16.5 Zhangjiagang Lanzhi Biotechnology Recent Developments
- 8.17 Guangzhou Kejin Material Technology
- 8.17.1 Guangzhou Kejin Material Technology Company Information
- 8.17.2 Guangzhou Kejin Material Technology Business Overview
- 8.17.3 Guangzhou Kejin Material Technology Medical Bioactive Glass Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Guangzhou Kejin Material Technology Medical Bioactive Glass Product Portfolio
- 8.17.5 Guangzhou Kejin Material Technology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Medical Bioactive Glass Value Chain Analysis
- 9.1.1 Medical Bioactive Glass Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Medical Bioactive Glass Production Mode & Process
- 9.2 Medical Bioactive Glass Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Bioactive Glass Distributors
- 9.2.3 Medical Bioactive Glass Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst